CAS: 1449236-96-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 3-[(1,1-Dioxido-1,2-benzisothiazol-3-yl)amino]phenyl chloroacetate REF: IN-DA00ABONCAS: 1449236-96-7 | 99% | A consultar | Vie 04 Oct 24 |
 | NMS-859 REF: TM-T12236CAS: 1449236-96-7 | 97.36% | 94,00 €~1.663,00 € | Vie 22 Nov 24 |
![3-[(1,1-Dioxido-1,2-benzisothiazol-3-yl)amino]phenyl chloroacetate](https://static.cymitquimica.com/products/IN/thumb/DA00ABON.jpg)
3-[(1,1-Dioxido-1,2-benzisothiazol-3-yl)amino]phenyl chloroacetate
CAS:1449236-96-7
Fórmula:
C15H12ClN3O3S
Pureza:
99%
Forma y color:
Solid
Peso molecular:
349.7921
Ref: IN-DA00ABON
| 1mg | 237,00 € | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 4 de Octubre de 2024
NMS-859
CAS:1449236-96-7
NMS-859 is a covalent VCP/p97 inhibitor with IC50 of 0.37 μM (60 μM ATP) and …
Fórmula:
C15H12ClN3O3S
Pureza:
97.36%
Forma y color:
Solid
Peso molecular:
349.79
Ref: TM-T12236
| 1mg | 94,00 € | ||
| 1ml | 215,00 € | ||
| 2mg | 132,00 € | ||
| 5mg | 185,00 € | ||
| 10mg | 279,00 € | ||
| 25mg | 444,00 € | ||
| 50mg | 634,00 € | ||
| 100mg | 852,00 € | ||
| 500mg | 1.663,00 € |
Entrega estimada en Estados Unidos, el Viernes 22 de Noviembre de 2024
